[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Avidity Biosciences, Inc. Common Stock Graphic](https://lunarcrush.com/gi/w:26/t:$rna.png) Avidity Biosciences, Inc. Common Stock (RNA)

Avidity Biosciences (RNA) stock is up today due to positive pre-BLA meeting with the FDA for del-zota, pushing the submission to Q1 2026. Buyout and partnership speculation continues to drive positive sentiment.

### About Avidity Biosciences, Inc. Common Stock
Avidity Biosciences, Inc. Common Stock (RNA) is a publicly traded stock in the healthcare sector.  
Avidity Biosciences, Inc. Common Stock uses the ticker $RNA for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$rna/insights)
- Avidity Biosciences, Inc. Common Stock (RNA) social dominance is up XXXXXX% from the previous week.
- Avidity Biosciences, Inc. Common Stock (RNA) posts created is up XX% from the previous week.

### Price: $XXXXX [#](/topic/$rna/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$rna/time-series/close.tsv)  
The stock is currently trading at $43.20, up XXXX% in the last XX hours, supported by buyout rumors and positive sentiment, despite recent negative price movement. The positive sentiment is likely driven by buyout speculation and positive data from related companies, while the recent negative price movement may be due to concerns about clinical holds.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2024-11-13  
**1-Year Low**: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX [#](/topic/$rna/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$rna/time-series/alt_rank.tsv)  
Avidity Biosciences, Inc. Common Stock (RNA) is currently AltRank #133 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +210  
**1 Month**: XXX -XX  
**6 Months**: XXX +16  
**1 Year**: XXX -XXX  
**1-Year High**: XXXXX on 2025-06-28  
**1-Year Low**: X on 2024-12-07  
  
  
### Galaxy Score: XX [#](/topic/$rna/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$rna/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XX +3  
**1 Month**: XX +23  
**6 Months**: XX -XX  
**1 Year**: XX -X  
**1-Year High**: XX on 2025-08-06  
**1-Year Low**: XX on 2025-05-11  
  
  
### Engagements: XXXXX [#](/topic/$rna/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$rna/time-series/interactions.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX +1.90%  
**1 Year**: XXXXXXXXX +73%  
**1-Year High**: XXXXXXX on 2025-08-06  
**1-Year Low**: XX on 2025-09-29  

| Social Network | X     |
| -------------- | -     |
| Engagements    | XXXXX |
  

  
  
### Mentions: XX [#](/topic/$rna/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$rna/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Week**: XX -XX%  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX -XX%  
**1 Year**: XXXXX +151%  
**1-Year High**: XXX on 2024-12-07  
**1-Year Low**: XX on 2025-09-29  

| Social Network | X   |
| -------------- | -   |
| Mentions       | XXX |
  

  
  
### Creators: XX [#](/topic/$rna/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$rna/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Avidity Biosciences, Inc. Common Stock (RNA) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XX -XX%  
**1 Month**: XXX -XX%  
**6 Months**: XXXXX +5.20%  
**1 Year**: XXXXX +271%  
**1-Year High**: XXX on 2025-06-28  
**1-Year Low**: XX on 2025-09-29  

The most influential creators that mention Avidity Biosciences, Inc. Common Stock in the last XX hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron)       | X    | XXXXX     | X     | XXX         |
| [@A1PHAEDGE](/creator/twitter/A1PHAEDGE)           | X    | XXX       | X     | XXX         |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)       | X    | XXXXXX    | X     | XXX         |
| [@JoseRestonVA](/creator/twitter/JoseRestonVA)     | X    | XXXXX     | X     | XXX         |
| [@adamfeuerstein](/creator/twitter/adamfeuerstein) | X    | XXXXXXX   | X     | XX          |
| [@Sanctuary_Bio](/creator/twitter/Sanctuary_Bio)   | X    | XXXXX     | X     | XX          |
| [@Biobeats99](/creator/twitter/Biobeats99)         | X    | XXX       | X     | XX          |
| [@themarketuni](/creator/twitter/themarketuni)     | X    | XXXXX     | X     | X           |

[View More](/list/creators/$rna/100)
  
  
### Sentiment: XX% [#](/topic/$rna/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rna/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +23%  
**6 Months**: XX% +25%  
**1 Year**: XX% +6%  
**1-Year High**: XXX% on 2025-01-27  
**1-Year Low**: XX% on 2025-09-27  

**Most Supportive Themes**
- **Buyout and Partnership Speculation:** (40%) Rumors of potential buyouts and partnerships, particularly with Novartis, are driving positive sentiment.
- **Positive Data and Clinical Trial Results:** (30%) Mentions of positive data readouts and clinical trial results, especially for related companies, are boosting confidence.
- **Strong Financial Position:** (15%) The company's strong balance sheet with significant cash reserves is viewed favorably.
  
**Most Critical Themes**
- **Discontinuation and Clinical Holds:** (15%)  Concerns about discontinuations and clinical holds in related RNA therapies are present.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXX      | XX% |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXX      | XX% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$rna/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$rna/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% +0.00997%  
**1 Month**: XXXXX% +0.004%  
**6 Months**: XXXXX% -XXXXX%  
**1 Year**: XXXXX% -XXXXXX%  
**1-Year High**: XXXXX% on 2024-12-07  
**1-Year Low**: XXXXXX% on 2025-09-29  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$rna/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$rna/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXXXX% on 2025-06-30  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$rna/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$rna/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$rna/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX -$0.98%  
**1 Month**: $XXXXXXXXXXXXX +$15%  
**6 Months**: $XXXXXXXXXXXXX +$103%  
**1 Year**: $XXXXXXXXXXXXX +$17%  
**1-Year High**: $XXXXXXXXXXXXX on 2025-10-09  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Avidity Biosciences, Inc. Common Stock in the last XX hours

[Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/dyne-therapeutics)
[Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn)
[Revolution Medicines, Inc. Common Stock (RVMD)](/topic/$rvmd)
[Merus N.V. Common Shares (MRUS)](/topic/$mrus)
[Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl)
[Arrowhead Research Corporation (ARWR)](/topic/$arwr)
[Akropolis (AKRO)](/topic/$akro)
[Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm)
[Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc)

**Top topics mentioned**
In the posts about Avidity Biosciences, Inc. Common Stock in the last XX hours

[stocks healthcare](/topic/stocks-healthcare), [dyne therapeutics](/topic/dyne-therapeutics), [$dyn](/topic/$dyn), [$pepg](/topic/$pepg), [stocks technology](/topic/stocks-technology), [acquisition](/topic/acquisition), [$abvx](/topic/$abvx), [$rvmd](/topic/$rvmd), [$mrus](/topic/$mrus), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks energy](/topic/stocks-energy), [coins base ecosystem](/topic/coins-base-ecosystem), [stocks](/topic/stocks), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [coins defi](/topic/coins-defi), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$mdgl](/topic/$mdgl), [coins dao](/topic/coins-dao), [$arwr](/topic/$arwr), [$akro](/topic/$akro), [$rytm](/topic/$rytm), [investment](/topic/investment), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [monaco](/topic/monaco), [stocks basic materials](/topic/stocks-basic-materials), [$nuvl](/topic/$nuvl), [coins arbitrum](/topic/coins-arbitrum), [telegram](/topic/telegram), [$apge](/topic/$apge), [cmc](/topic/cmc), [$ions](/topic/$ions), [$wolf](/topic/$wolf), [defi development corp](/topic/defi-development-corp), [$yeti](/topic/$yeti), [$imte](/topic/$imte), [realty income corp](/topic/realty-income-corp), [stocks real estate](/topic/stocks-real-estate), [$bpmc](/topic/$bpmc), [$qure](/topic/$qure), [$srpt](/topic/$srpt), [$sats](/topic/$sats), [$phat](/topic/$phat), [$crsp](/topic/$crsp), [$pcvx](/topic/$pcvx), [$ptct](/topic/$ptct), [$aapl](/topic/$aapl), [$ionq](/topic/$ionq), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$imvt](/topic/$imvt), [$110golden](/topic/$110golden), [$idya](/topic/$idya), [market cap](/topic/market-cap), [alnylam pharmaceuticals inc](/topic/alnylam-pharmaceuticals-inc), [$alny](/topic/$alny), [$slno](/topic/$slno), [stocks industrials](/topic/stocks-industrials), [$dfdv](/topic/$dfdv), [$uuuu](/topic/$uuuu), [stocks financial services](/topic/stocks-financial-services), [advanced micro devices](/topic/advanced-micro-devices), [send this](/topic/send-this), [$ocul](/topic/$ocul), [$mlys](/topic/$mlys), [$cytk](/topic/$cytk), [$ntla](/topic/$ntla), [$prme](/topic/$prme), [$crnx](/topic/$crnx), [vertex protocol](/topic/vertex-protocol), [coins exchange tokens](/topic/coins-exchange-tokens), [money](/topic/money), [stockmarket](/topic/stockmarket), [$onc](/topic/$onc), [alibaba group](/topic/alibaba-group), [jose](/topic/jose), [approved](/topic/approved), [targets](/topic/targets), [$legn](/topic/$legn), [crispr](/topic/crispr), [boring](/topic/boring), [legit](/topic/legit), [$cava](/topic/$cava), [$vor](/topic/$vor), [$prva](/topic/$prva), [$anab](/topic/$anab), [$apld](/topic/$apld), [$arvn](/topic/$arvn), [$10b](/topic/$10b), [prediction](/topic/prediction), [$atxs](/topic/$atxs), [$elvn](/topic/$elvn), [$rprx](/topic/$rprx), [$rdnt](/topic/$rdnt), [$axsm](/topic/$axsm), [$open](/topic/$open), [open opendoor technologies inc](/topic/open-opendoor-technologies-inc), [$bntx](/topic/$bntx), [howmet aerospace inc](/topic/howmet-aerospace-inc), [$plug](/topic/$plug), [$lac](/topic/$lac), [$usar](/topic/$usar)

### Top Social Posts [#](/topic/$rna/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"VRME showing power late-day💥Sitting at $XXXX and holding gains golden cross upcoming PR and treasury news could send this higher fast⚡🔥 $YETI $IMTE $O $AAGH $RCAT $GNE $AXSM $IDYA $KYMR $BRZE $SYRE $DENLI $XENE $RIOT $RNA $ACLX $BIO $BHVN"  
[X Link](https://x.com/A1PHAEDGE/status/1979336047910883476) [@A1PHAEDGE](/creator/x/A1PHAEDGE) 2025-10-17T23:57Z XXX followers, XX engagements


"VRME showing power late-day💥Sitting at $XXXX and holding gains golden cross upcoming PR and treasury news could send this higher fast⚡🔥 $WOLF $DFDV $NXTT $QUBT $DRUG $RGC $BTQ $SLB $HAL $OXY $COP $PXD $RIC $RDNT $GNE $AXSM $IDYA $KYMR $BRZE $SYRE $DENLI $XENE $RIOT $RNA"  
[X Link](https://x.com/A1PHAEDGE/status/1979335926456430876) [@A1PHAEDGE](/creator/x/A1PHAEDGE) 2025-10-17T23:57Z XXX followers, XXX engagements


"After-hours breakout 👀 $ VRME hitting $XXXX with momentum building fast Golden cross + upcoming PR + treasury news = perfect setup 💎⚡ $YETI $IMTE $O $AAGH $RCAT $GNE $AXSM $IDYA $KYMR $BRZE $SYRE $DENLI $XENE $RIOT $RNA $ACLX $BIO $BHVN"  
[X Link](https://x.com/A1PHAEDGE/status/1979325760134615164) [@A1PHAEDGE](/creator/x/A1PHAEDGE) 2025-10-17T23:16Z XXX followers, XX engagements


"VRME holding firm after hours at $XXXX 💪 Golden cross ✅ Catalysts stacking ✅ $XXXX breakout zone next could be ready for liftoff🚀📈 $WOLF $DFDV $NXTT $QUBT $DRUG $RGC $BTQ $SLB $HAL $OXY $COP $PXD $RIC $RDNT $GNE $AXSM $IDYA $KYMR $BRZE $SYRE $DENLI $XENE $RIOT $RNA $ACLX"  
[X Link](https://x.com/A1PHAEDGE/status/1979325430273577015) [@A1PHAEDGE](/creator/x/A1PHAEDGE) 2025-10-17T23:15Z XXX followers, XXX engagements